ChemPartner PharmaTech Co Ltd Financial Flexibility Index
ChemPartner PharmaTech Co Ltd financial flexibility index. ChemPartner PharmaTech Co Ltd (300149) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥94.83 Million (operating CF CN¥28.21 Million minus capex CN¥66.62 Million) represents 0% of total liabilities (CN¥1.06 Billion). Explore capital reinvestment ratio of ChemPartner PharmaTech Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ChemPartner PharmaTech Co Ltd (2007–2025)
Financial flexibility index of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. Check 300149 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
ChemPartner PharmaTech Co Ltd Financial Flexibility Index by Year (2007–2025)
ChemPartner PharmaTech Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for ChemPartner PharmaTech Co Ltd. For the full cash flow conversion analysis, see 300149 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥252.97 Million | CN¥190.50 Million | CN¥732.59 Million | ▲ +10.2% |
| 2024 | 0.31x | CN¥237.45 Million | CN¥168.21 Million | CN¥757.75 Million | ▼ -13.4% |
| 2023 | 0.36x | CN¥352.28 Million | CN¥150.99 Million | CN¥973.44 Million | ▼ -13.1% |
| 2022 | 0.42x | CN¥598.66 Million | CN¥262.46 Million | CN¥1.44 Billion | ▲ +39.7% |
| 2021 | 0.30x | CN¥664.22 Million | CN¥378.22 Million | CN¥2.23 Billion | ▼ -32.5% |
| 2020 | 0.44x | CN¥737.19 Million | CN¥343.16 Million | CN¥1.67 Billion | ▲ +37.8% |
| 2019 | 0.32x | CN¥469.30 Million | CN¥215.07 Million | CN¥1.46 Billion | ▲ +3.8% |
| 2018 | 0.31x | CN¥353.07 Million | CN¥243.19 Million | CN¥1.14 Billion | ▼ -5.2% |
| 2017 | 0.33x | CN¥67.65 Million | CN¥63.43 Million | CN¥207.73 Million | ▼ -90.7% |
| 2016 | 3.52x | CN¥81.71 Million | CN¥71.26 Million | CN¥23.23 Million | ▼ -10.2% |
| 2015 | 3.91x | CN¥126.02 Million | CN¥100.69 Million | CN¥32.19 Million | ▲ +27.8% |
| 2014 | 3.06x | CN¥136.56 Million | CN¥59.63 Million | CN¥44.60 Million | ▼ -5.8% |
| 2013 | 3.25x | CN¥109.50 Million | CN¥46.32 Million | CN¥33.70 Million | ▼ -51.8% |
| 2012 | 6.74x | CN¥180.00 Million | CN¥55.09 Million | CN¥26.72 Million | ▲ +360.5% |
| 2011 | 1.46x | CN¥32.73 Million | CN¥11.66 Million | CN¥22.37 Million | ▼ -37.4% |
| 2010 | 2.34x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.12 Million | ▲ +155.2% |
| 2009 | 0.92x | CN¥32.11 Million | CN¥13.28 Million | CN¥35.04 Million | ▼ -43.1% |
| 2008 | 1.61x | CN¥46.03 Million | CN¥21.70 Million | CN¥28.57 Million | ▲ +144.9% |
| 2007 | 0.66x | CN¥28.64 Million | CN¥22.19 Million | CN¥43.53 Million | — |